HEALTH Share Price Performance
€1.42
-2.33 (-62.13%)
5.2% overvalued intrinsic discount
€1.35
Fair Value
Price €1.42
AnalystConsensusTarget €1.35
AnalystHighTarget €2.50
AnalystLowTarget €1.00
Fair Value€1.35
Share Pricen/a
Nightingale Health Oyj Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
HEALTH Community Narratives
AN
Fair Value €1.35 5.2% overvalued intrinsic discount
New US And Singapore Labs Will Improve Healthcare Efficiency
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
Fair Value €2.5 43.2% undervalued intrinsic discount
Preventative Care And Multiomics Adoption Will Support A Stronger Long Term Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value €1 42.0% overvalued intrinsic discount
Prevention Funding And Slower Healthcare Shifts Will Likely Restrain This Business Long Term
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
New US And Singapore Labs Will Improve Healthcare Efficiency
Key Takeaways Nightingale Health's innovative disease detection from a single blood sample and international deals could boost global market penetration and revenue expansion. Strategic vertical integration, low burn rate, and possible stock listings aim to enhance operational efficiency, financial stability, and investor interest.Read more
46
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
€1.35
5.2% overvalued intrinsic discount
Fair Value
Profit Margin
6.78%
Future PE
103.16x
Price in 2029
€1.59
Preventative Care And Multiomics Adoption Will Support A Stronger Long Term Outlook
Catalysts About Nightingale Health Oyj Nightingale Health Oyj provides blood based molecular profiling that helps detect and track chronic disease risk for use in both health care and medical research. What are the underlying business or industry changes driving this perspective?Read more
10
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
€2.5
43.2% undervalued intrinsic discount
Fair Value
Profit Margin
7.25%
Future PE
171.06x
Price in 2029
€2.95
Prevention Funding And Slower Healthcare Shifts Will Likely Restrain This Business Long Term
Catalysts About Nightingale Health Oyj Nightingale Health Oyj provides blood based molecular profiling and risk assessment tools for prevention focused health care and medical research. What are the underlying business or industry changes driving this perspective?Read more
5
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€1
42.0% overvalued intrinsic discount
Fair Value
Profit Margin
7.06%
Future PE
71.06x
Price in 2029
€1.18
Trending Discussion
Recently Updated Narratives
AN
HEALTH: Future Outlook Will Rely On U.S. Lab Permit And Cardiometabolic Screening Potential
Fair Value: €1.35 5.2% overvalued intrinsic discount
6 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Preventative Care And Multiomics Adoption Will Support A Stronger Long Term Outlook
Fair Value: €2.5 43.2% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Prevention Funding And Slower Healthcare Shifts Will Likely Restrain This Business Long Term
Fair Value: €1 42.0% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Nightingale Health Oyj Key Details
About HEALTH
- Founded
- 2002
- Employees
- 103
- CEO
- WebsiteView website
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
